Department of Physiology, Chicago College of Osteopathic Medicine, Midwestern University, IL 60515, USA.
World J Gastroenterol. 2013 Jan 28;19(4):482-91. doi: 10.3748/wjg.v19.i4.482.
To investigate retrograde tracer transport by gastric enteric neurons in insulin resistant mice with low or high glycosylated hemoglobin (Hb).
Under anesthesia, the retrograde tracer fluorogold was superficially injected into the fundus or antrum using a microsyringe in KK Cg-Ay/J mice prior to onset of type 2 diabetes mellitus (T2DM; 4 wk of age), at onset of T2DM (8 wk of age), and after 8, 16, or 24 wk of untreated T2DM and in age-matched KK/HIJ mice. Six days later, mice were sacrificed by CO₂ narcosis followed by pneumothorax. Stomachs were removed and fixed. Sections from fundus, corpus and antrum were excised and mounted on a glass slide. Tracer-labeled neurons were viewed using a microscope and manually counted. Data were expressed as the number of neurons in short and long descending and ascending pathways and in local fundus and antrum pathways, and the number of neurons in all regions labeled after injection of tracer into either the fundus or the antrum.
By 8 wk of age, body weights of KKAy mice (n = 12, 34 ± 1 g) were heavier than KK mice (n = 17, 29 ± 1 g; F (4, 120) = 4.414, P = 0.002] and glycosylated Hb was higher [KK: (n = 7), 4.97% ± 0.04%; KKAy: (n = 6), 6.57% ± 0.47%; F (1, 26) = 24.748, P < 0.001]. The number of tracer labeled enteric neurons was similar in KK and KKAy mice of all ages in the short descending pathway [F (1, 57) = 2.374, P = 0.129], long descending pathway [F (1, 57) = 0.922, P = 0.341], local fundus pathway [F (1, 53) = 2.464, P = 0.122], local antrum pathway [F (1, 57) = 0.728, P = 0.397], and short ascending pathway [F (1, 53) = 2.940, P = 0.092]. In the long ascending pathway, fewer tracer-labeled neurons were present in KKAy as compared to KK mice [KK: (n = 34), 302 ± 17; KKAy: (n = 29), 230 ± 15; F (1, 53) = 8.136, P = 0.006]. The number of tracer-labeled neurons was decreased in all mice by 16 wk as compared to 8 wk of age in the short descending pathway [8 wk: (n = 15), 305 ± 26; 16 wk: (n = 13), 210 ± 30; F (4, 57) = 9.336, P < 0.001], local antrum pathway [8 wk: (n = 15), 349 ± 20; 16 wk: (n = 13), 220 ± 33; F (4, 57) = 8.920, P < 0.001], short ascending pathway [8 wk: (n = 14), 392 ± 15; 16 wk: (n = 14), 257 ± 33; F (4, 53) = 17.188, P < 0.001], and long ascending pathway [8 wk: (n = 14), 379 ± 39; 16 wk: (n = 14), 235 ± 26; F (4, 53) = 24.936, P < 0.001. The number of tracer-labeled neurons decreased at 24 wk of age in the local fundus pathway [8 wk: (n = 14), 33 ± 11; 24 wk: (n = 12), 3 ± 2; F (4, 53) = 5.195, P = 0.001] and 32 wk of age in the long descending pathway [8 wk: (n = 15), 16 ± 3; 32 wk: (n = 12), 3 ± 2; F (4, 57) = 2.944, P = 0.028]. The number of tracer-labeled enteric neurons was correlated to final body weight for local fundus and ascending pathways [KK: (n = 34), r = -0.746, P < 0.001; KKAy: (n = 29), r = -0.842, P < 0.001] as well as local antrum and descending pathways [KK (n = 36), r = -0.660, P < 0.001; KKAy (n = 31), r = -0.622, P < 0.001). In contrast, glycosylated Hb was not significantly correlated to number of tracer-labeled neurons [KK (n = 17), r = -0.164, P = 0.528; KKAy (n = 16), r = -0.078, P = 0.774].
Since uncontrolled T2DM did not uniformly impair tracer transport in gastric neurons, long ascending neurons may be more susceptible to persistent hyperglycemia and low effective insulin.
研究低或高糖化血红蛋白(Hb)的胰岛素抵抗小鼠中胃肠神经元的逆行示踪剂转运。
在 2 型糖尿病(T2DM)发病前(4 周龄)、发病时(8 周龄)以及未治疗的 T2DM 后 8、16 或 24 周,在 KK Cg-Ay/J 小鼠的胃底或胃窦用微量注射器浅注逆行示踪剂荧光金,随后将其麻醉处死,通过 CO₂ 麻醉和气胸来取出胃。切除胃底、胃体和胃窦的切片,并安装在载玻片上。使用显微镜观察并手动计数示踪剂标记的神经元。数据表示为短和长降路径以及局部胃底和胃窦路径中的神经元数量,以及在将示踪剂注入胃底或胃窦后标记的所有区域中的神经元数量。
8 周龄时,KKAy 小鼠(n=12,体重 34±1g)的体重比 KK 小鼠(n=17,体重 29±1g;F(4,120)=4.414,P=0.002)重,糖化 Hb 也更高[KK:(n=7),4.97%±0.04%;KKAy:(n=6),6.57%±0.47%;F(1,26)=24.748,P<0.001]。在所有年龄段的 KK 和 KKAy 小鼠中,短降路径中的示踪剂标记肠神经元数量相似[F(1,57)=2.374,P=0.129]、长降路径[F(1,57)=0.922,P=0.341]、局部胃底路径[F(1,53)=2.464,P=0.122]、局部胃窦路径[F(1,57)=0.728,P=0.397]和短升路径[F(1,53)=0.922,P=0.341]。在长升路径中,与 KK 小鼠相比,KKAy 小鼠中标记的神经元数量较少[KK:(n=34),302±17;KKAy:(n=29),230±15;F(1,53)=8.136,P=0.006]。与 8 周龄相比,所有小鼠在 16 周龄时短降路径[8 周龄:(n=15),305±26;16 周龄:(n=13),210±30;F(4,57)=9.336,P<0.001]、局部胃窦路径[8 周龄:(n=15),349±20;16 周龄:(n=13),220±33;F(4,57)=8.920,P<0.001]、短升路径[8 周龄:(n=14),392±15;16 周龄:(n=14),257±33;F(4,53)=17.188,P<0.001]和长升路径[8 周龄:(n=14),379±39;16 周龄:(n=14),235±26;F(4,53)=24.936,P<0.001]中的示踪剂标记神经元数量减少。在 24 周龄时,局部胃底路径中的标记神经元数量减少[8 周龄:(n=14),33±11;24 周龄:(n=12),3±2;F(4,53)=5.195,P=0.001]和 32 周龄时的长降路径[8 周龄:(n=15),16±3;32 周龄:(n=12),3±2;F(4,57)=2.944,P=0.028]。局部胃底和升路径的标记神经元数量与最终体重呈正相关[KK:(n=34),r=-0.746,P<0.001;KKAy:(n=29),r=-0.842,P<0.001]以及局部胃窦和降路径[KK(n=36),r=-0.660,P<0.001;KKAy(n=31),r=-0.622,P<0.001]。相比之下,糖化 Hb 与标记神经元的数量没有显著相关性[KK:(n=17),r=-0.164,P=0.528;KKAy:(n=16),r=-0.078,P=0.774]。
由于未控制的 T2DM 并没有使胃神经元的逆行示踪剂运输普遍受损,长升神经元可能更容易受到持续高血糖和低有效胰岛素的影响。